Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global CT Contrast Media Market by Type (Iohexol, Iodixanol, Iopamidol, Ioversol, Others), By Application (Hospitals, Clinics) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global CT Contrast Media Market by Type (Iohexol, Iodixanol, Iopamidol, Ioversol, Others), By Application (Hospitals, Clinics) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 237147 4200 Pharma & Healthcare 377 210 Pages 4.6 (32)
                                          

Market Overview:


The global CT contrast media market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of chronic diseases, rising demand for minimally invasive surgeries, and technological advancements in CT scanners. By type, the iohexol segment is expected to account for the largest share of the global CT contrast media market in 2018. By application, hospitals are expected to account for the largest share of the global CT contrast media market in 2018. Geographically, North America is expected to dominate the global CT contrast media market in 2018.


Global CT Contrast Media Industry Outlook


Product Definition:


CT contrast media is a substance used to improve the visibility of internal organs and tissues on CT scans. Contrast media can be used to improve the accuracy of a diagnosis or to help guide treatment.


Iohexol:


Iohexol, a colorless liquid with a slight odor, is an organic compound mainly used as a contrast medium in computed tomography (CT) scans. It is also used as an intravenous fluid replacement therapy to maintain the blood volume and pressure in patients suffering from low blood pressure or hypovolemic state.


Iodixanol:


It has high water solubility and molecular weight which allows it to be easily absorbed by the body after oral administration. Iodixanol is used as a radiopaque contrast media in CT scans and MRI procedures.


The product was approved by the U.


Application Insights:


Based on application, the global CT contrast media market is segmented into hospitals and clinics. The hospitals segment dominated the market in 2017 owing to factors such as increasing number of surgeries, growing geriatric population, and rising awareness among patients regarding timely treatment. Moreover, an increase in hospital-based diagnostic imaging centers has further propelled demand for CT imaging solutions across the globe.


The clinics segment is expected to grow at a lucrative rate over the forecast period due to factors such as availability of low cost healthcare services in developing countries like India and China along with advancements made by various companies for development of cost-effective contrast media products specifically designed for outpatient usage. For instance, IsoFluxion¢â‚¬â„¢s new product line namely Fluxion M which provides fast scanning time without any sedation requirement thus making it highly preferred amongst clinicians working outstation or remote locations where anesthesia might be difficult to provide.


Regional Analysis:


North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, increasing prevalence of cardiovascular diseases and growing adoption of advanced diagnostic techniques. Moreover, rising demand for minimally invasive surgeries is also expected to drive regional growth over the forecast period.


Asia Pacific is expected to witness lucrative growth during the forecast period due to improving healthcare facilities and economic development in emerging countries such as China and India. Furthermore, an increase in chronic disease burden coupled with a rise in consumer disposable income levels will boost regional demand further on account of rapidly expanding medical tourism industry. Increasing investments by international players for establishing their business foothold are also anticipated to contribute toward market growth over next eight years.


Growth Factors:


  • Increasing incidence of cardiovascular diseases (CVDs) and other chronic diseases requiring diagnosis and treatment with CT contrast media.
  • Growing demand for minimally invasive diagnostic procedures that use CT contrast media to improve image quality and enable more accurate diagnoses.
  • Advances in medical imaging technology that have led to the development of new types of CT contrast media, such as micro-bubbles, that offer improved performance over older products.
  • The increasing number of elderly people who are susceptible to CVDs and other chronic diseases, and who require regular diagnostic testing using CT contrast media.

Scope Of The Report

Report Attributes

Report Details

Report Title

CT Contrast Media Market Research Report

By Type

Iohexol, Iodixanol, Iopamidol, Ioversol, Others

By Application

Hospitals, Clinics

By Companies

GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma, Sanochemia, Tyco Healthcare, GE Healthcare, Grupo Juste, Daiichi Sankyo, Takeda, Fuji Pharma, Towaseiyaku, Hikari Pharmaceutical, Consentis Diagnostics GmbH, T2Pharma

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

210

Number of Tables & Figures

147

Customization Available

Yes, the report can be customized as per your need.


Global CT Contrast Media Market Report Segments:

The global CT Contrast Media market is segmented on the basis of:

Types

Iohexol, Iodixanol, Iopamidol, Ioversol, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Clinics

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. GE Healthcare
  2. Bayer
  3. Bracco Imaging
  4. Guerbet Group
  5. Hengrui Medicine
  6. Lantheus
  7. YRPG
  8. BeiLu Pharma
  9. Sanochemia
  10. Tyco Healthcare
  11. GE Healthcare
  12. Grupo Juste
  13. Daiichi Sankyo
  14. Takeda
  15. Fuji Pharma
  16. Towaseiyaku
  17. Hikari Pharmaceutical
  18. Consentis Diagnostics GmbH
  19. T2Pharma

Global CT Contrast Media Market Overview


Highlights of The CT Contrast Media Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Iohexol
    2. Iodixanol
    3. Iopamidol
    4. Ioversol
    5. Others
  1. By Application:

    1. Hospitals
    2. Clinics
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the CT Contrast Media Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global CT Contrast Media Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


CT contrast media is a type of imaging that uses contrast agents to create images of organs and tissues. CT scans use a large amount of radiation, so they are not typically used for routine medical care. However, they can be very helpful in diagnosing certain medical conditions.

Some of the major companies in the ct contrast media market are GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma, Sanochemia, Tyco Healthcare, GE Healthcare, Grupo Juste, Daiichi Sankyo, Takeda, Fuji Pharma, Towaseiyaku, Hikari Pharmaceutical, Consentis Diagnostics GmbH, T2Pharma.

The ct contrast media market is expected to register a CAGR of 5.8%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 CT Contrast Media Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 CT Contrast Media Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 CT Contrast Media Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the CT Contrast Media Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global CT Contrast Media Market Size & Forecast, 2018-2028       4.5.1 CT Contrast Media Market Size and Y-o-Y Growth       4.5.2 CT Contrast Media Market Absolute $ Opportunity

Chapter 5 Global CT Contrast Media Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 CT Contrast Media Market Size Forecast by Type
      5.2.1 Iohexol
      5.2.2 Iodixanol
      5.2.3 Iopamidol
      5.2.4 Ioversol
      5.2.5 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global CT Contrast Media Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 CT Contrast Media Market Size Forecast by Applications
      6.2.1 Hospitals
      6.2.2 Clinics
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global CT Contrast Media Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 CT Contrast Media Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America CT Contrast Media Analysis and Forecast
   9.1 Introduction
   9.2 North America CT Contrast Media Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America CT Contrast Media Market Size Forecast by Type
      9.6.1 Iohexol
      9.6.2 Iodixanol
      9.6.3 Iopamidol
      9.6.4 Ioversol
      9.6.5 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America CT Contrast Media Market Size Forecast by Applications
      9.10.1 Hospitals
      9.10.2 Clinics
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe CT Contrast Media Analysis and Forecast
   10.1 Introduction
   10.2 Europe CT Contrast Media Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe CT Contrast Media Market Size Forecast by Type
      10.6.1 Iohexol
      10.6.2 Iodixanol
      10.6.3 Iopamidol
      10.6.4 Ioversol
      10.6.5 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe CT Contrast Media Market Size Forecast by Applications
      10.10.1 Hospitals
      10.10.2 Clinics
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific CT Contrast Media Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific CT Contrast Media Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific CT Contrast Media Market Size Forecast by Type
      11.6.1 Iohexol
      11.6.2 Iodixanol
      11.6.3 Iopamidol
      11.6.4 Ioversol
      11.6.5 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific CT Contrast Media Market Size Forecast by Applications
      11.10.1 Hospitals
      11.10.2 Clinics
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America CT Contrast Media Analysis and Forecast
   12.1 Introduction
   12.2 Latin America CT Contrast Media Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America CT Contrast Media Market Size Forecast by Type
      12.6.1 Iohexol
      12.6.2 Iodixanol
      12.6.3 Iopamidol
      12.6.4 Ioversol
      12.6.5 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America CT Contrast Media Market Size Forecast by Applications
      12.10.1 Hospitals
      12.10.2 Clinics
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) CT Contrast Media Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) CT Contrast Media Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) CT Contrast Media Market Size Forecast by Type
      13.6.1 Iohexol
      13.6.2 Iodixanol
      13.6.3 Iopamidol
      13.6.4 Ioversol
      13.6.5 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) CT Contrast Media Market Size Forecast by Applications
      13.10.1 Hospitals
      13.10.2 Clinics
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 CT Contrast Media Market: Competitive Dashboard
   14.2 Global CT Contrast Media Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 GE Healthcare
      14.3.2 Bayer
      14.3.3 Bracco Imaging
      14.3.4 Guerbet Group
      14.3.5 Hengrui Medicine
      14.3.6 Lantheus
      14.3.7 YRPG
      14.3.8 BeiLu Pharma
      14.3.9 Sanochemia
      14.3.10 Tyco Healthcare
      14.3.11 GE Healthcare
      14.3.12 Grupo Juste
      14.3.13 Daiichi Sankyo
      14.3.14 Takeda
      14.3.15 Fuji Pharma
      14.3.16 Towaseiyaku
      14.3.17 Hikari Pharmaceutical
      14.3.18 Consentis Diagnostics GmbH
      14.3.19 T2Pharma

Our Trusted Clients

Contact Us